Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,686
Total Claims
$1.7M
Drug Cost
724
Beneficiaries
$2,413
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-86%
Opioid rate vs peers
0.4% vs 2.6% avg
+126%
Cost per patient vs peers
$2,413 vs $1,068 avg
+48%
Brand preference vs peers
13.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.4%
Opioid Rate
62
Opioid Claims
$479
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,213 claims · $1.4M
Generic: 14,358 claims · $328K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lipase/Protease/Amylase | 234 | $242K |
| Sitagliptin Phosphate | 169 | $138K |
| Apixaban | 181 | $100K |
| Adalimumab | 13 | $97K |
| Icosapent Ethyl | 226 | $76K |
| Linagliptin | 133 | $72K |
| Lipase/Protease/Amylase | 61 | $67K |
| Dulaglutide | 45 | $66K |
| Dapagliflozin Propanediol | 49 | $51K |
| Empagliflozin | 38 | $47K |
| Linaclotide | 56 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 63 | $30K |
| Sacubitril/Valsartan | 40 | $29K |
| Rivaroxaban | 35 | $29K |
| Sitagliptin Phos/Metformin Hcl | 42 | $27K |
Prescribing Profile
Patient Profile
77
Avg Age
54%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data